Ryan Lynch
CIK 1709271 · See Remarks · last filed 2025-12-17
Ryan Lynch is a corporate insider who has filed 8 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing, for GLYC, was dated Dec 17, 2025. Across all open-market trades the lifetime net is −$50.8K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
8
-$50.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (GLYC) Delisted | See Remarks | 8,378 | $15.70 | $131.5K | $0 | 1 | 2025-12-17 |
| CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | PAO | 18,059 | $8.37 | $151.2K | -$50.8K | 7 | 2019-08-19 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-17 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Grant (A) | +12,378 | $0 | EDGAR |
| 2019-08-19 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Grant (A) | +14,063 | $0 | EDGAR |
| 2019-04-02 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Tax (F) | −1,043 | -$12.6K | EDGAR |
| 2019-01-08 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-04-03 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Tax (F) | −961 | -$22.0K | EDGAR |
| 2018-01-08 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-09-18 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Mixed | — | -$17.7K | EDGAR |
| 2017-07-10 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Grant (A) | +6,000 | $0 | EDGAR |